Analysts' Actions: HP, VVUS, JNPR, K

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Assurant ( AIZ) downgraded at Sterne Agee to Neutral, Sterne Agee said. Valuation call, based on a $52 price target.

Alexion Pharmaceuticals ( ALXN) upgraded at UBS to Buy from Neutral, UBS said. $99 price target. Upgrade to buy on PNH, NMO and margins.

Brocade ( BRCD) upgraded to buy at TheStreet Ratings.

Community Health ( CYH) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $33 price target. Industry is leveraged to better economic growth.

DryShips ( DRYS) downgraded to sell at TheStreet Ratings.

Ericsson ( ERIC) upgraded at JP Morgan to Overweight, JP Morgan said. Expectations are low and the company has been gaining market share.

HCA ( HCA) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. Company is a market leader and the group appears more attractive.

Human Genome ( HGSI) downgraded at Collins Stewart from Buy to Neutral, Collins Stewart said. $10 price target. Benlysta sales could fall short of expectations.

Intuit ( INTU) rated new Hold at Stifel. Valuation cal.

ITC ( ITC) upgraded at Wunderlich from Hold to Buy, Wunderlich said. $85 price target. Company should continue to deliver higher earnings and is trading at an attractive valuation.

Itron ( ITRI) downgraded at BofA/Merrill to Underperform, Bank of America/Merrill Lynch said. Valuation call, based on a $45 price target.

Juniper Networks ( JNPR) downgraded at FBR from Outperform to Market Perform, FBR Capital Markets said. $21 price target. Seeing more evidence of potential product delays.

Kellogg ( K) upgraded at Deutsche to from Hold to Buy, Deutsche Bank said. Pringles purchase could prove to be an inflection point for the company. $57 price target.

Level 3 ( LVLT) upgraded at Morgan Stanley from Equal-weight to Overweight, Morgan Stanley said. $31 price target. Estimates also boosted, given higher secular demand.

MercadoLibre ( MELI) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $100 price target. Valuation call, as the stock is up 96% since October.

Principal Financial ( PFG) upgraded at Sterne Agee from Neutral to Buy, Sterne Agee said. $35 price target. Company has solid long-term earnings growth potential.

Volcano ( VOLC) downgraded at Feltl from Strong Buy to Buy, Feltl & Co. said. Recent guidance has been mixed.

Vivus ( VVUS) upgraded at Brean Murray from Sell to Hold, Brean Murray said. Company will probably receive FDA approval for Qnexa in April.

STOCK COMMENTS / EPS CHANGES

Avago Technologies ( AVGO) numbers raised at Jefferies. Shares of AVGO now seen reaching $43, Jefferies said. Estimates also raised on good visibility into growth. Buy rating.

HomeAway ( AWAY) numbers reduced at Credit Suisse. Shares of AWAY now seen reaching $27, according to Credit Suisse. Estimates were also cut, as the company is spending more on potential growth. Neutral rating.

Blackbaud ( BLKB) numbers raised at Jefferies. Shares of BLKB now seen reaching $28, Jefferies said. Estimates also raised on underlying trends. Hold rating.

Chico's ( CHS) target raised at to $15, UBS said. Target raised on near term momentum. Neutral rating.

Clean Harbors ( CLH) numbers raised at JP Morgan. Shares of CLH now seen reaching $80, according to JP Morgan. Estimates also increased, as the company is executing well in a robust growth environment. Overweight rating.

Campbell Soup ( CPB) estimates boosted at Morgan Stanley. CPB estimates were upped through 2014, Morgan Stanley said. Company is seeing better soup sales. Underweight rating and new $30 price target.

Discover Financial ( DFS) numbers increased at Guggenheim. DFS estimates were raised through 2013, Guggenheim said. Company is buying back more stock. Buy rating and new $34 price target.

Fluor ( FLR) numbers raised at UBS. Shares of FLR now seen reaching $71, UBS said. Estimates also raised on headwinds turning to tailwinds. Buy rating.

Frontier ( FTR) estimates upped at Morgan Stanley through 2014, Morgan Stanley said. Company has a new focus on increasing sales growth. Equal-weight rating.

Hewlett-Packard ( HPQ) estimates cut at Credit Suisse. HPQ estimates were reduced through 2013, Credit Suisse said. Company faces macro headwinds and lower services margins. Neutral rating and $30 price target.

Nabors Industries ( NBR) numbers raised at UBS. Shares of NBR now seen reaching $24, UBS said. Estimates also raised as new CEO comes out of the gate strongly. Neutral rating.

TJX ( TJX) numbers raised at UBS. Shares of TJX now seen reaching $39, UBS said. Estimates also raised as all engines at work to drive growth. Buy rating.

Tempur-Pedic ( TPX) numbers raised at Oppenheimer. Shares of TPX now seen reaching $85, Oppenheimer said. Estimates also raised on upbeat analyst day. Outperform rating.

Vivus ( VVUS) numbers raised at Jefferies. Shares of VVUS now seen reaching $11, Jefferies said. Estimates also raised on Qnexa approval. Underperform rating.

>To submit a news tip, email: tips@thestreet.com.

RELATED STORIES:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

More from Stocks

The Stock Market Has Every Reason to See a Fresh Rally

The Stock Market Has Every Reason to See a Fresh Rally

3 Simple Tips on Investing From TheStreet's Jim Cramer

3 Simple Tips on Investing From TheStreet's Jim Cramer

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Tesla's Supercharger Network Is Booming -- Here's Why That's a Concern

Tesla's Supercharger Network Is Booming -- Here's Why That's a Concern

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly

Attention 60 Minutes: Google Isn't the Only Big-Tech Monopoly